Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Modelling optimal vaccination strategies against Covid-19 in a context of Gamma variant predominance in Brazil

View ORCID ProfileLeonardo Souto Ferreira, View ORCID ProfileGabriel Berg de Almeida, View ORCID ProfileMarcelo Eduardo Borges, View ORCID ProfileLorena Mendes Simon, View ORCID ProfileSilas Poloni, View ORCID ProfileÂngela Maria Bagattini, View ORCID ProfileMichelle Quarti Machado da Rosa, View ORCID ProfileJosé Alexandre Felizola Diniz Filho, View ORCID ProfileRicardo de Souza Kuchenbecker, View ORCID ProfileSuzi Alves Camey, View ORCID ProfileRoberto André Kraenkel, View ORCID ProfileRenato Mendes Coutinho, View ORCID ProfileCristiana Maria Toscano
doi: https://doi.org/10.1101/2021.11.19.21266590
Leonardo Souto Ferreira
1São Paulo State University (UNESP), Institute for Theoretical Physics, Brazil
2Observatório Covid-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Leonardo Souto Ferreira
  • For correspondence: leonardo.souto@unesp.br
Gabriel Berg de Almeida
3São Paulo State University (UNESP), Infectious Diseases Department, Botucatu Medical School (FMB), Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriel Berg de Almeida
Marcelo Eduardo Borges
2Observatório Covid-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcelo Eduardo Borges
Lorena Mendes Simon
4Federal University of Goiás (UFG), Department of Ecology, Postgraduate Programme in Ecology and Evolution, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lorena Mendes Simon
Silas Poloni
1São Paulo State University (UNESP), Institute for Theoretical Physics, Brazil
2Observatório Covid-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Silas Poloni
Ângela Maria Bagattini
5Federal University of Goiás (UFG), Institute of Tropical Pathology and Public Health, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ângela Maria Bagattini
Michelle Quarti Machado da Rosa
5Federal University of Goiás (UFG), Institute of Tropical Pathology and Public Health, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michelle Quarti Machado da Rosa
José Alexandre Felizola Diniz Filho
2Observatório Covid-19 BR
4Federal University of Goiás (UFG), Department of Ecology, Postgraduate Programme in Ecology and Evolution, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José Alexandre Felizola Diniz Filho
Ricardo de Souza Kuchenbecker
6Federal University of Rio Grande do Sul (UFRGS), Postgraduate Programme of Epidemiology (IPTSP), Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricardo de Souza Kuchenbecker
Suzi Alves Camey
7Federal University of Rio Grande do Sul (UFRGS), Institute of Mathematics and Statistics, Department of Statistics, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Suzi Alves Camey
Roberto André Kraenkel
1São Paulo State University (UNESP), Institute for Theoretical Physics, Brazil
2Observatório Covid-19 BR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Roberto André Kraenkel
Renato Mendes Coutinho
2Observatório Covid-19 BR
8Federal University of ABC (UFABC), Center for Mathematics, Computation and Cognition, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Renato Mendes Coutinho
Cristiana Maria Toscano
5Federal University of Goiás (UFG), Institute of Tropical Pathology and Public Health, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cristiana Maria Toscano
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Brazil experienced moments of collapse in its health system throughout 2021, driven by a timid initial vaccination strategy against Covid-19, combined with the emergence of variants of interest (VOC). Mathematical modelling has been used to subsidize decision-makers in public health planning. Considering the vaccine products available, effectiveness estimates, the emergence of Gamma as the predominant VOC circulating in 2021, and national estimated doses available for the next several months, we developed a Markov-chain mathematical modelling approach to evaluate optimal strategies for Covid-19 vaccination in Brazil in terms of Covid deaths averted. Our main findings are that in order to reach higher vaccination impact in Brazil, Covid-19 immunization strategies should include recovering vaccination coverage rates in high-risk groups reaching higher coverage; expanding vaccination to younger age groups should be considered only after ensuring at least 80% coverage in older age groups; reducing the interval between doses of AZD1222 from 12 to 8 weeks. We also demonstrate that the latter is only feasible if accompanied by an increase in vaccine supply of at least 50% in the next six month period.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Brazilian National Council for Scientific and Technological Development (CNPq) - Process # 402834/2020-8 (request for proposals MCTIC/CNPq/FNDCT/MS/SCTIE/Decit N° 07/2020). The funding sources played no role in the study design, collection, analysis, or interpretation of the data, writing the report, or deciding to submit the paper for publication. LSF received a master's scholarship from Coordination of Superior Level Staff Improvement (CAPES) (finance code 001). GBA received a technological and industrial scholarship from CNPq (grant number 301796/2021-1). MEB received a technological and industrial scholarship from CNPq (grant number 315854/2020-0). LMS received a technological and industrial scholarship from CNPq (grant number 315866/2020-9). SP was supported by São Paulo State Research Support Foundation (FAPESP) (grant number: 2018/24037-4). AMB received a technological and industrial scholarship from CNPq (grant number 402834/2020-8). MQMR received a postdoctoral scholarship from CAPES (grant number 305269/2020-8). RSK has been supported by CNPq (proc. 312378/2019-0). JAFD-F has been supported by the CNPq productivity fellowship and the National Institutes for Science and Technology in Ecology, Evolution and Biodiversity Conservation (INCT-EEC), supported by MCTIC/CNPq (proc. 465610/2014-5) and FAPEG (proc. 201810267000023). RAK has been supported by CNPq (grant number: 311832/2017-2) and FAPESP (contract number: 2016/01343-7). CMT has been supported by the CNPq productivity fellowship and the National Institute of Science and Technology for Health Technology Assessment (IATS) (proc: 465518/2014-1).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors state that the database used in the analyses are available as a supplementary file to the paper and can be provided to interested researchers upon reasonable request.

https://github.com/covid19br/paper_markov

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modelling optimal vaccination strategies against Covid-19 in a context of Gamma variant predominance in Brazil
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modelling optimal vaccination strategies against Covid-19 in a context of Gamma variant predominance in Brazil
Leonardo Souto Ferreira, Gabriel Berg de Almeida, Marcelo Eduardo Borges, Lorena Mendes Simon, Silas Poloni, Ângela Maria Bagattini, Michelle Quarti Machado da Rosa, José Alexandre Felizola Diniz Filho, Ricardo de Souza Kuchenbecker, Suzi Alves Camey, Roberto André Kraenkel, Renato Mendes Coutinho, Cristiana Maria Toscano
medRxiv 2021.11.19.21266590; doi: https://doi.org/10.1101/2021.11.19.21266590
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Modelling optimal vaccination strategies against Covid-19 in a context of Gamma variant predominance in Brazil
Leonardo Souto Ferreira, Gabriel Berg de Almeida, Marcelo Eduardo Borges, Lorena Mendes Simon, Silas Poloni, Ângela Maria Bagattini, Michelle Quarti Machado da Rosa, José Alexandre Felizola Diniz Filho, Ricardo de Souza Kuchenbecker, Suzi Alves Camey, Roberto André Kraenkel, Renato Mendes Coutinho, Cristiana Maria Toscano
medRxiv 2021.11.19.21266590; doi: https://doi.org/10.1101/2021.11.19.21266590

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (164)
  • Allergy and Immunology (417)
  • Anesthesia (93)
  • Cardiovascular Medicine (867)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (398)
  • Epidemiology (8597)
  • Forensic Medicine (4)
  • Gastroenterology (391)
  • Genetic and Genomic Medicine (1775)
  • Geriatric Medicine (170)
  • Health Economics (376)
  • Health Informatics (1252)
  • Health Policy (625)
  • Health Systems and Quality Improvement (472)
  • Hematology (198)
  • HIV/AIDS (380)
  • Infectious Diseases (except HIV/AIDS) (10354)
  • Intensive Care and Critical Care Medicine (554)
  • Medical Education (193)
  • Medical Ethics (51)
  • Nephrology (214)
  • Neurology (1692)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (330)
  • Occupational and Environmental Health (451)
  • Oncology (934)
  • Ophthalmology (265)
  • Orthopedics (104)
  • Otolaryngology (172)
  • Pain Medicine (115)
  • Palliative Medicine (40)
  • Pathology (256)
  • Pediatrics (541)
  • Pharmacology and Therapeutics (257)
  • Primary Care Research (210)
  • Psychiatry and Clinical Psychology (1788)
  • Public and Global Health (3877)
  • Radiology and Imaging (629)
  • Rehabilitation Medicine and Physical Therapy (324)
  • Respiratory Medicine (525)
  • Rheumatology (208)
  • Sexual and Reproductive Health (171)
  • Sports Medicine (159)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)